Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Aequus Pharmaceuticals Inc (AQSZF)

Aequus Pharmaceuticals Inc (AQSZF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0044 +25.00%
on 12/05/24
0.0078 -29.49%
on 11/22/24
-0.0033 (-37.50%)
since 11/07/24
3-Month
0.0044 +25.00%
on 12/05/24
0.0094 -41.49%
on 10/30/24
-0.0095 (-63.33%)
since 08/27/24
52-Week
0.0044 +25.00%
on 12/05/24
0.0266 -79.32%
on 12/15/23
-0.0178 (-76.39%)
since 12/08/23

Most Recent Stories

More News
Press Release for Early Warning Report Regarding Aequus Pharmaceuticals Inc.

VANCOUVER, British Columbia, July 23, 2022 (GLOBE NEWSWIRE) -- Doug Janzen, of 2820 – 200 Granville St., Vancouver, BC, V6C 1S4, today announced that on...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Resumes Trading on TSX Venture Exchange

VANCOUVER, British Columbia, July 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) announces that further to our news...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Signs Exclusive Distribution Agreement with SCOPE Ophthalmics for Canadian Distribution Rights of Dry Eye Products

VANCOUVER, British Columbia, July 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”) is...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Provides General Update and Reports Record 2021 Financial Results

Also reports Financial Results for the 3 months ended March 31, 2022 VANCOUVER, British Columbia, July 01, 2022 (GLOBE NEWSWIRE) -- Aequus...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Provides Update on Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, June 13, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Provides Update on Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 27, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Provides Update on Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 06, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Announces Delay in Filing Annual Financial Statements

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Announces Short Term Loan

VANCOUVER, British Columbia, May 02, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF) (“Aequus” or the “Company”)...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)
Aequus Announces Director Resignation

VANCOUVER, British Columbia, April 22, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical...

AQS.VN : 0.005 (unch)
AQSZF : 0.0055 (+7.84%)

Key Turning Points

3rd Resistance Point 0.0065
2nd Resistance Point 0.0063
1st Resistance Point 0.0059
Last Price 0.0055
1st Support Level 0.0053
2nd Support Level 0.0051
3rd Support Level 0.0047

See More

52-Week High 0.0266
Fibonacci 61.8% 0.0181
Fibonacci 50% 0.0155
Fibonacci 38.2% 0.0129
Last Price 0.0055
52-Week Low 0.0044

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar